Decreased spliceosome fidelity and egl-8 intron retention inhibit mTORC1 signaling to promote longevity

Nat Aging. 2022 Sep;2(9):796-808. doi: 10.1038/s43587-022-00275-z. Epub 2022 Sep 19.

Abstract

Changes in splicing fidelity are associated with loss of homeostasis and aging, yet only a handful of splicing factors have been shown to be causally required to promote longevity, and the underlying mechanisms and downstream targets in these paradigms remain elusive. Surprisingly, we found a hypomorphic mutation within ribonucleoprotein RNP-6/poly(U)-binding factor 60 kDa (PUF60), a spliceosome component promoting weak 3'-splice site recognition, which causes aberrant splicing, elevates stress responses and enhances longevity in Caenorhabditis elegans. Through genetic suppressor screens, we identify a gain-of-function mutation within rbm-39, an RNP-6-interacting splicing factor, which increases nuclear speckle formation, alleviates splicing defects and curtails longevity caused by rnp-6 mutation. By leveraging the splicing changes induced by RNP-6/RBM-39 activities, we uncover intron retention in egl-8/phospholipase C β4 (PLCB4) as a key splicing target prolonging life. Genetic and biochemical evidence show that neuronal RNP-6/EGL-8 downregulates mammalian target of rapamycin complex 1 (mTORC1) signaling to control organismal lifespan. In mammalian cells, PUF60 downregulation also potently and specifically inhibits mTORC1 signaling. Altogether, our results reveal that splicing fidelity modulates lifespan through mTOR signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caenorhabditis elegans / genetics
  • Caenorhabditis elegans Proteins* / genetics
  • Introns / genetics
  • Longevity / genetics
  • Mammals / genetics
  • Mechanistic Target of Rapamycin Complex 1 / genetics
  • RNA Splicing Factors / genetics
  • Ribonucleoproteins / genetics
  • Spliceosomes* / genetics

Substances

  • Caenorhabditis elegans Proteins
  • RNA Splicing Factors
  • Ribonucleoproteins
  • Mechanistic Target of Rapamycin Complex 1